Skip to main content
. 2020 Sep 23;41(11):1377–1386. doi: 10.1038/s41401-020-00519-x

Table 3.

Clinical trials of chloroquine in COVID-19 registered with FDAa.

Interventions Conditions Locations/Countries Numberb
Chloroquine COVID-19 Australia 1
Chloroquine COVID-19 Brazil 3
Chloroquine COVID-19 Canada 3
Chloroquine COVID-19 China 2
Chloroquine COVID-19 Colombia 2
Chloroquine COVID-19 Denmark 1
Chloroquine COVID-19 Egypt 6
Chloroquine COVID-19 France 4
Chloroquine COVID-19 Germany 3
Chloroquine COVID-19 Greece 1
Chloroquine COVID-19 Iran 5
Chloroquine COVID-19 Ireland 1
Chloroquine COVID-19 Italy 1
Chloroquine COVID-19 Jordan 1
Chloroquine COVID-19 Mexico 2
Chloroquine COVID-19 Netherlands 1
Chloroquine COVID-19 Norway 1
Chloroquine COVID-19 Pakistan 2
Chloroquine COVID-19 South Africa 1
Chloroquine COVID-19 Spain 3
Chloroquine COVID-19 Thailand 1
Chloroquine COVID-19 United Kingdom 1
Chloroquine COVID-19 United States 6
Chloroquine COVID-19 Vietnam 1

aThere are total 58 studies as May 13th, 2020 (Searching key word “COVID-19” and “chloroquine”).

bSome clinical trials are multiple site studies. Data as April 15th, 2020.